Explore CD160 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is expressed by CD56dimCD16+ cells whereas among circulating T cells its expression is mainly restricted to TCRgd bearing cells and to TCRab+CD8brightCD95+CD56+CD28-CD27-cells. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules. [provided by RefSeq, Jul 2008]
| Target ID |
GM-T57907
|
| Target Name |
CD160
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
11126
|
| Gene ID |
100065657 (Equus caballus), 100125861 (Felis catus), 104971522 (Bos taurus), 11126 (Homo sapiens) 483158 (Canis lupus familiaris), 502585 (Rattus norvegicus), 54215 (Mus musculus), 696832 (Macaca mulatta)
|
| Target Alternative Names |
BY55,By55,CD160,CD160 antigen,Cd160,NK1,NK28,Natural killer cell receptor BY55,RGD1563598
|
| Uniprot Accession |
O95971,O88875
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target, Immuno-oncology Target
|
| Gene Ensembl |
ENSECAG00000010888, ENSG00000117281, ENSCAFG00845010227, ENSMUSG00000038304, ENSMMUG00000007969
|
| Target Classification |
Checkpoint-Immuno Oncology
|
Pre-made viral vector of CD160 cDNA Clones/ORF Plasmid
CD160 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo11126 | Pre-made Human CD160/NK1/BY55 siRNA oligo Duplex | 11126 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo502585 | Pre-made Rat Cd160/RGD1563598 siRNA oligo Duplex | 502585 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo54215 | Pre-made Mouse Cd160/By55 siRNA oligo Duplex | 54215 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo696832 | Pre-made Cynomolgus/Rhesus macaque CD160 siRNA oligo Duplex | 696832 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100125861 | Pre-made Cat/Feline CD160/BY55 siRNA oligo Duplex | 100125861 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo483158 | Pre-made Dog/Canine CD160 siRNA oligo Duplex | 483158 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo104971522 | Pre-made Bovines/Cattle CD160 siRNA oligo Duplex | 104971522 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100065657 | Pre-made Equine/Horse CD160 siRNA oligo Duplex | 100065657 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CD160 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T57907-Ab | Human | Anti-Human CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T57907-Ab | Rat | Anti-Rat CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T57907-Ab | Mouse | Anti-Mouse CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T57907-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T57907-Ab | Cat/Feline | Anti-Cat/Feline CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T57907-Ab | Dog/Canine | Anti-Dog/Canine CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T57907-Ab | Bovines/Cattle | Anti-Bovines/Cattle CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T57907-Ab | Equine/Horse | Anti-Equine/Horse CD160 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CD160 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T57907-Ag | Human | Human CD160 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T57907-Ag | Rat | Rat CD160 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T57907-Ag | Mouse | Mouse CD160 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T57907-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque CD160 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T57907-Ag | Cat/Feline | Cat/Feline CD160 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T57907-Ag | Dog/Canine | Dog/Canine CD160 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T57907-Ag | Bovines/Cattle | Bovines/Cattle CD160 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T57907-Ag | Equine/Horse | Equine/Horse CD160 VLP (virus-like particle) | HEK293 | Products Developing |